This activity is supported by an educational grant from Merck & Co., Inc.
Expiration Date: 1/15/2020
Human papillomavirus (HPV)-related, non-cervical cancers are on the rise in the United States, especially in males. Despite this trend, HPV vaccination rates are still…go to activity»
This activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 12/1/2019
Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients with GCA are at increased risk for various short-…go to activity»
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.
Expiration Date: 12/21/2019
The therapeutic goals for Pulmonary Arterial Hypertension are to improve the hemodynamic parameters, delay disease progression, improving quality of life and exercise…go to activity»
This activity is supported by an educational grant from ViiV Healthcare, a joint venture of GlaxoSmithKline, Pfizer, and Shionogi.
Expiration Date: 12/12/2019
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds…go to activity»
This activity is supported by an educational grant from Novo Nordisk, Inc.
Expiration Date: 12/6/2019
The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the United States. According to the US Centers for…go to activity»
This activity is supported by an independent educational grant from Amarin Pharma Inc.
Expiration Date: 12/4/2019
This innovative, 30-minute, CME activity features 5 leading experts addressing complex issues when treating patients with residual cardiovascular disease (CVD) risk…go to activity»